Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more
scdvszc

White Paper: Health Technology Assessment 2015-2024 Trends in Europe

Advance your understanding of European market access for medical devices

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

EU HTA Publication Digest: Implementing the EU HTA regulation and joint clinical assessment: a multi-stakeholder perspective from Italy

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. 

In a recent publication, Meregaglia et al. explored the expected impact of implementing the EU HTA Regulation and Joint Clinical Assessment (JCA) through a multi-stakeholder case study in Italy. 

Based on interviews with key HTA stakeholders in Italy, the authors found that JCA may improve the quality of clinical assessment and support faster, more equitable access to innovation, although its impact will depend on the need for additional country-level analyses. The study also identified key implementation challenges for developers, including short timelines and limited evidence, and highlighted the importance of harmonized evidence standards, HTA training, and stronger stakeholder collaboration to support effective implementation.

Access the full-text article here.